
==== Front
Cureus
Cureus
2168-8184
Cureus
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.c192
Correction
Correction: Lipoprotein Ratios: Correlation With Thyroid Profile and Glycated Hemoglobin (HbA1c) Among Diabetes Mellitus Patients
Correction
Muacevic Alexander
Adler John R
Banerjee Ayan 1
LNU Jagriti 2
LNU Prabhat 2
Bansal Akash 2
1 Biochemistry, All India Institute of Medical Sciences, Patna, Patna, IND
2 Biochemistry, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, IND
Prabhat LNU drprabhat12811281@yahoo.in
13 9 2024
9 2024
13 9 2024
16 9 c192Copyright © 2024, Banerjee et al.
2024
Banerjee et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Lipoprotein Ratios: Correlation With Thyroid Profile and Glycated Hemoglobin (HbA1c) Among Diabetes Mellitus Patients
==== Body
pmcThis article has been corrected to fix several typos causing confusion regarding the study design and dates. The title has been changed from 'Lipoprotein Ratios: Correlation With Glycated Hemoglobin (HbA1c) Among Thyroid Disorders Patients' to 'Lipoprotein Ratios: Correlation With Thyroid Profile and Glycated Hemoglobin (HbA1c) Among Diabetes Mellitus Patients'. Additionally, the Materials & Methods section has been updated as follows:

In the first paragraph, the study dates have been corrected from June 2022 - July 2022 to June 2023 - July 2023

In the third paragraph, the following sentence has been revised to indicate a previous history of drug treatment: "Individuals with a previous history of hyperthyroidism, hypothyroidism, serious infections and malignancy, or those taking any drugs known to cause disturbance of lipid metabolism, were also excluded from the study." changed to "Individuals with a previous history of drug treatment for hyperthyroidism, hypothyroidism, serious infections and malignancy, or those taking any drugs known to cause disturbance of lipid metabolism, were also excluded from the study."

No competing interests declared.
